Cargando…
Glatiramer Acetate in Treatment of Multiple Sclerosis: A Toolbox of Random Co-Polymers for Targeting Inflammatory Mechanisms of both the Innate and Adaptive Immune System?
Multiple sclerosis is a disease of the central nervous system, resulting in the demyelination of neurons, causing mild to severe symptoms. Several anti-inflammatory treatments now play a significant role in ameliorating the disease. Glatiramer acetate (GA) is a formulation of random polypeptide copo...
Autores principales: | Jalilian, Babak, Einarsson, Halldór Bjarki, Vorup-Jensen, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3509598/ https://www.ncbi.nlm.nih.gov/pubmed/23203082 http://dx.doi.org/10.3390/ijms131114579 |
Ejemplares similares
-
Properties and prospects of adjuvants in influenza vaccination - messy precipitates or blessed opportunities?
por: Jalilian, Babak, et al.
Publicado: (2013) -
Glatiramer acetate in the treatment of multiple sclerosis
por: Tselis, Alex, et al.
Publicado: (2007) -
The role of glatiramer acetate in the early treatment of multiple sclerosis
por: Brandes, David W
Publicado: (2010) -
Spasticity in multiple sclerosis and role of glatiramer acetate treatment
por: Meca-Lallana, Jose Eustasio, et al.
Publicado: (2015) -
Follow-on glatiramer acetate
por: Cohen, Jeffrey A., et al.
Publicado: (2018)